Key statistics
As of last trade Biontech SE (0A3M:LSE) traded at 107.73, -14.30% below its 52-week high of 125.70, set on Jun 03, 2025.
52-week range
| Open | 108.50 |
|---|---|
| High | 107.73 |
| Low | 107.73 |
| Bid | 105.00 |
| Offer | 110.00 |
| Previous close | 110.50 |
| Average volume | 678.43 |
|---|---|
| Shares outstanding | 259.03m |
| Free float | 233.52m |
| P/E (TTM) | -- |
| Market cap | 28.55bn USD |
| EPS (TTM) | -2.78 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 14:37 GMT.
More ▼
- EQS-News: BIO-Europe Spring® 2026 Charts the Future of Life Sciences from Lisbon’s Shores
- BioNTech veröffentlicht am 10. März 2026 Ergebnisse für das vierte Quartal und das Geschäftsjahr 2025 und informiert über operativen Fortschritt
- BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026
- BioNTech ernennt Kylie Jimenez zur neuen Personalvorständin
- BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer
- J.P. Morgan Healthcare Conference: signals for a re-rating of the sector are gaining momentum
- BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference
- BioNTech präsentiert auf der 44. J.P. Morgan Healthcare-Konferenz Updates zur Geschäftsentwicklung und Schwerpunkte für das Jahr 2026
- BioNTech schließt Übernahme von CureVac N.V. samt damit verbundener Nachangebotsfrist ab und stärkt so die einzigartige Position im mRNA-Feld
- BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field
More ▼
